Consolidated Statement Of Profit Or Loss

ONO PHARMACEUTICAL CO., LTD. - Filing #7710975

Concept	2018-04-01 to 2019-03-31	2018-04-01 to 2019-03-31	2018-04-01 to 2019-03-31	2018-04-01 to 2019-03-31	2017-04-01 to 2018-03-31	2017-04-01 to 2018-03-31	2017-04-01 to 2018-03-31	2017-04-01 to 2018-03-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue	—	—	288,634,000,000 JPY	—	—	261,836,000,000 JPY	—	—
Cost of sales	—	—	83,829,000,000 JPY	—	—	65,391,000,000 JPY	—	—
Gross profit	—	—	204,805,000,000 JPY	—	—	196,445,000,000 JPY	—	—
Selling, general and administrative expenses	—	—	70,033,000,000 JPY	—	—	68,055,000,000 JPY	—	—
Other income	—	—	646,000,000 JPY	—	—	3,255,000,000 JPY	—	—
Other expenses	—	—	3,400,000,000 JPY	—	—	2,139,000,000 JPY	—	—
Operating profit (loss)	—	—	62,010,000,000 JPY	—	—	60,684,000,000 JPY	—	—
Finance income	—	—	3,282,000,000 JPY	—	—	3,277,000,000 JPY	—	—
Finance costs	—	—	150,000,000 JPY	—	—	36,000,000 JPY	—	—
Share of profit (loss) of investments accounted for using equity method	—	—	-1,000,000 JPY	—	—	-4,000,000 JPY	—	—
Profit (loss) before tax	—	—	65,141,000,000 JPY	—	—	63,922,000,000 JPY	—	—
Income tax expense	—	—	13,462,000,000 JPY	—	—	13,525,000,000 JPY	—	—
Profit (loss)	51,539,000,000 JPY	51,539,000,000 JPY	51,679,000,000 JPY	140,000,000 JPY	50,284,000,000 JPY	50,397,000,000 JPY	113,000,000 JPY	50,284,000,000 JPY
Profit (loss) attributable to
Owners of parent	—	—	51,539,000,000 JPY	—	—	50,284,000,000 JPY	—	—
Non-controlling interests	—	—	140,000,000 JPY	—	—	113,000,000 JPY	—	—
Earnings (loss) per share
Basic earnings (loss) per share	—	—	100.25	—	—	97.00	—	—
Diluted earnings (loss) per share	—	—	100.24	—	—	96.99	—	—